Akebia Therapeutics will conduct one-on-one meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum where management will discuss the company's commercial products and clinical pipeline for rare kidney diseases.
为什么重要. 投资者和分析师将深入了解公司的战略方向和管线进展，从而影响股票价格和投资决策。
Akebia was founded in 2007
Akebia was founded in 2007 and is headquartered in Waltham, Massachusetts.
a biopharmaceutical company
WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, Dr. Steven Burke, Chi…
During meetings, management will discuss its commercial products and clinical stage, differentiated pipeline assets for rare kidney diseases.
